These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23399877)

  • 1. Safety and efficacy of acamprosate for the treatment of alcohol dependence.
    Yahn SL; Watterson LR; Olive MF
    Subst Abuse; 2013; 6():1-12. PubMed ID: 23399877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.
    Witkiewitz K; Saville K; Hamreus K
    Ther Clin Risk Manag; 2012; 8():45-53. PubMed ID: 22346357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
    Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol Dependence.
    Frye MA; Hinton DJ; Karpyak VM; Biernacka JM; Gunderson LJ; Feeder SE; Choi DS; Port JD
    J Clin Psychopharmacol; 2016 Dec; 36(6):669-674. PubMed ID: 27755217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials.
    Mason BJ; Ownby RL
    CNS Spectr; 2000 Feb; 5(2):58-69. PubMed ID: 18296999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
    Mason BJ; Lehert P
    Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
    Maisel NC; Blodgett JC; Wilbourne PL; Humphreys K; Finney JW
    Addiction; 2013 Feb; 108(2):275-93. PubMed ID: 23075288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy].
    Gahr M; Kölle MA; Schönfeldt-Lecuona C
    Nervenarzt; 2013 May; 84(5):584-9. PubMed ID: 22892944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of acamprosate as a treatment against alcohol relapse.
    Kufahl PR; Watterson LR; Olive MF
    Expert Opin Drug Discov; 2014 Nov; 9(11):1355-69. PubMed ID: 25258174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
    Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
    Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate: safety and tolerability in the treatment of alcohol dependence.
    Rosenthal RN; Gage A; Perhach JL; Goodman AM
    J Addict Med; 2008 Mar; 2(1):40-50. PubMed ID: 21768971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.